top of page

SIGNAL

A decentralized discovery platform for emerging therapeutic devices in ME/CFS and Long COVID

This project is built around a device lending library. Patients diagnosed with ME/CFS or Long COVID borrow promising therapeutic devices, shipped directly to their homes at no cost to them, for a 1-3 month lending period. While borrowing, participants contribute standardized longitudinal data through the Brain Inflammation Collaborative/Solve ME unhide® Solve Together platform. This allows each lending cycle to be a real-world research opportunity. 

​​

​

SIGNAL will address three unmet needs in the ME/CFS and Long COVID community:

 

  1. Generate real-world evidence on patients' responses to promising therapeutic devices, with a focus on identifying patient subgroups for which each treatment is most effective.

  2. Improve patient access by offering a "try before you buy" device lending library, so that expensive devices that might help are no longer out of reach.

  3. Share findings quickly with the community, not just in academic papers years from now. Share accessible reports that tell patients which devices show promise, for whom, and for which symptoms.

​

Patients interested in participating in the SIGNAL study and device lending library can sign up and follow along as SIGNAL launches here:

​​​

Vielight

Vielight Neuro Gamma
(Photobiomodulation)

Transcranial + intranasal near-infrared light (810 nm, 40 Hz gamma). Light penetrates a few centimeters into the brain tissue. 

Truvaga
(Cervical Vagus Nerve Stimulation)

Handheld, non-invasive vagus nerve stimulation held to the neck.

Truvaga.jpg

Meet the Team

bottom of page